Literature DB >> 19240959

Interferon beta, birth weight and pregnancy in multiple sclerosis.

Kerstin Hellwig, Heike Agne, Ralf Gold.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19240959     DOI: 10.1007/s00415-009-5014-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  4 in total

Review 1.  Risk factors in miscarriage: a review.

Authors:  A García-Enguídanos; M E Calle; J Valero; S Luna; V Domínguez-Rojas
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2002-05-10       Impact factor: 2.435

2.  The reproductive effects of beta interferon therapy in pregnancy: a longitudinal cohort.

Authors:  R Boskovic; R Wide; J Wolpin; D J Bauer; G Koren
Journal:  Neurology       Date:  2005-09-27       Impact factor: 9.910

3.  Reproductive counselling, treatment and course of pregnancy in 73 German MS patients.

Authors:  K Hellwig; N Brune; A Haghikia; T Müller; S Schimrigk; V Schwödiauer; R Gold
Journal:  Acta Neurol Scand       Date:  2008-01-16       Impact factor: 3.209

4.  Is in utero early-exposure to interferon beta a risk factor for pregnancy outcomes in multiple sclerosis?

Authors:  F Patti; T Cavallaro; S Lo Fermo; A Nicoletti; V Cimino; R Vecchio; P Laisa; R Zarbo; M Zappia
Journal:  J Neurol       Date:  2008-07-28       Impact factor: 4.849

  4 in total
  2 in total

1.  Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancy.

Authors:  Nadja Borisow; Andrea Döring; Caspar F Pfueller; Friedemann Paul; Jan Dörr; Kerstin Hellwig
Journal:  EPMA J       Date:  2012-06-22       Impact factor: 6.543

2.  The German Multiple Sclerosis and Pregnancy Registry: rationale, objective, design, and first results.

Authors:  Sandra Thiel; Andrea I Ciplea; Ralf Gold; Kerstin Hellwig
Journal:  Ther Adv Neurol Disord       Date:  2021-11-22       Impact factor: 6.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.